Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Gustavo Cornejo
Coordinator, Regulatory
Senior VP Health Sciences
Overview
Research
More
Collaboration
(47)
Francisco Moreno
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Emmanuel Katsanis
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Bruce Coull
Mutual work: 9 Proposals﹒4 Grants
Collaboration Details
Jordan Karp
Mutual work: 4 Proposals﹒2 Grants
Collaboration Details
Sachin Chaudhary
Mutual work: 2 Grants
Collaboration Details
Page 1 of 10
Previous page
Next page
Grants
(29)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir
Active
·
2023
·
$0 / $1.6M
·
External
undefined (CD)
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety
A First-in-human (FIH) Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
Active
·
2023
·
$0 / $749.8K
·
External
undefined (CD)
neuroscience,
epilepsy,
clinical trial,
drug resistance,
inhibitory interneurons
Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease
Active
·
2023
·
$0 / $597.6K
·
External
undefined (CD)
parkinson's disease,
dose escalation,
clinical trial,
neurodegenerative diseases
Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)
Active
·
2023
·
$0 / $568.2K
·
External
undefined (CD)
colorectal cancer,
treatment,
clinical trial,
dkn-01,
chemotherapy
A Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10mg as Adjunctive Therapy in Adult Participants with
Active
·
2023
·
$0 / $502.5K
·
External
undefined (CD)
pharmacology,
mental health,
clinical trial,
pain management,
therapy
Page 1 of 6
Previous page
Next page